beta

EYEGW

EyeGate Pharmaceuticals, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.

Market Cap: 60.1 Thousand

Primary Exchange: NASDAQ

Website: http://www.eyegatepharma.com

Shares Outstanding: 4.63 Million

Float:

Dividend: (%)

Beta:

Sector: Health Technology

Industry: Pharmaceuticals: Other

Ethical Flags

Longest drawdown: 682 trading days

From: 2015-08-12 To: 2019-11-01

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud